- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 16, 2025 | 58.9M sh |
| Operating Cash Flow | Q2 2025 · Jan 31, 2025 | $1.14M |
| Operating Cash Flow restated | Q2 2025 · Jan 31, 2024 | −$110.5K |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | −$646.31K |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$961.32K |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $3.12M |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $4M |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $3.12M |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $4M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $34.91K |
| Current Assets | Q2 2025 · Jul 31, 2024 | $206.27K |
| Total Assets | Q2 2025 · Jan 31, 2025 | $2.48M |
| Total Assets | Q2 2025 · Jul 31, 2024 | $3.04M |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 62.68M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 62.68M sh |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Diluted restated | Q2 2025 · Jan 31, 2024 | −$0.01 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Basic restated | Q2 2025 · Jan 31, 2024 | −$0.01 |
| Sga Expense restated | Q2 2025 · Jan 31, 2024 | $158.6K |
| Sga Expense restated | Q2 2025 · Jan 31, 2024 | $322.59K |
| Net Income restated | Q2 2025 · Jan 31, 2024 | −$155.63K |
| Net Income restated | Q2 2025 · Jan 31, 2024 | −$413.79K |
| Operating Income restated | Q2 2025 · Jan 31, 2024 | −$326.9K |
| Operating Income restated | Q2 2025 · Jan 31, 2024 | −$659.19K |
| Gross Profit | Q2 2025 · Jan 31, 2024 | $0 |
| Gross Profit | Q2 2025 · Jan 31, 2024 | $0 |
| Cost Of Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |
| Cost Of Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |
| Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |
| Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |